LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,019,000 | -90.5% | 9,063 | -86.9% | 0.02% | -88.6% |
Q4 2021 | $10,680,000 | -34.5% | 69,141 | -40.9% | 0.22% | -28.8% |
Q3 2021 | $16,305,000 | -23.5% | 117,033 | -28.0% | 0.31% | -22.2% |
Q2 2021 | $21,327,000 | -44.1% | 162,565 | -35.1% | 0.40% | -51.0% |
Q1 2021 | $38,179,000 | +98.6% | 250,436 | +29.5% | 0.81% | +87.5% |
Q4 2020 | $19,228,000 | +129.7% | 193,339 | +120.1% | 0.43% | +52.1% |
Q3 2020 | $8,371,000 | +59.7% | 87,823 | +87.3% | 0.28% | +49.5% |
Q2 2020 | $5,243,000 | +42.7% | 46,878 | -7.2% | 0.19% | -4.0% |
Q1 2020 | $3,673,000 | +195.5% | 50,514 | +323.7% | 0.20% | +247.4% |
Q4 2019 | $1,243,000 | -39.2% | 11,921 | -42.0% | 0.06% | -49.6% |
Q3 2019 | $2,046,000 | +2.2% | 20,556 | +17.2% | 0.11% | +14.1% |
Q2 2019 | $2,002,000 | -53.3% | 17,541 | -48.5% | 0.10% | -57.0% |
Q1 2019 | $4,283,000 | -56.2% | 34,074 | -52.8% | 0.23% | -66.8% |
Q4 2018 | $9,787,000 | +37.7% | 72,125 | +178.6% | 0.69% | +79.5% |
Q3 2018 | $7,106,000 | +91.7% | 25,889 | +44.7% | 0.39% | +73.1% |
Q2 2018 | $3,707,000 | -33.1% | 17,895 | -46.6% | 0.22% | -44.2% |
Q1 2018 | $5,538,000 | +4.0% | 33,533 | -13.8% | 0.40% | -4.5% |
Q4 2017 | $5,325,000 | +10.9% | 38,889 | +10.3% | 0.42% | +4.5% |
Q3 2017 | $4,802,000 | +21.1% | 35,272 | +8.0% | 0.40% | +9.6% |
Q2 2017 | $3,966,000 | +25.1% | 32,670 | +9.1% | 0.37% | +15.1% |
Q1 2017 | $3,170,000 | -90.4% | 29,951 | -90.8% | 0.32% | -72.0% |
Q4 2016 | $33,023,000 | +5.9% | 325,000 | +6.4% | 1.14% | +11.2% |
Q3 2016 | $31,172,000 | -19.5% | 305,424 | -6.0% | 1.02% | -27.7% |
Q2 2016 | $38,742,000 | -5.4% | 324,824 | -15.1% | 1.41% | -5.2% |
Q1 2016 | $40,975,000 | +5.4% | 382,624 | +6.7% | 1.49% | +11.4% |
Q4 2015 | $38,882,000 | +16.1% | 358,624 | -8.3% | 1.34% | +28.9% |
Q3 2015 | $33,489,000 | -5.1% | 391,000 | +11.8% | 1.04% | +3.8% |
Q2 2015 | $35,275,000 | +233.2% | 349,600 | +154.6% | 1.00% | +229.7% |
Q1 2015 | $10,587,000 | – | 137,300 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |